18850 - Human Photoallergy Test

N/ACompletedNCT02751463

Bayer54 enrolled

Overview

To evaluate the potential of a test material to produce a photoallergic response.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Sunscreening Agents

Interventions

Sunscreening Sport Spray Rest (BAY987519)DRUG

50 μl/ cm\*2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. 24 hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. 48 hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.(Formulation Number - RB# Y51-002 )

Untreated skinOTHER

One site is patched without treatment as control

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * be male or female between the ages of 18 and 60 inclusive; * be lightly pigmented (Fitzpatrick Skin Type I, II, III); * have read and signed the written Informed Consent Form and have completed a Health Insurance Portability and Accountability Act (HIPAA) Authorization Form in conformance with 45CFR Parts 160 and 164; * be in general good health as determined by the subject's medical history and in the discretion of the investigator. Exclusion Criteria: * have a visible sunburn; * have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses; * have a known hypersensitivity or allergy against any of the active and non-active ingredients of the investigational products. * subjects who are employees of the CRO and/or Bayer or is a household member of an employee

Locations (1)

Unnamed facility

Piscataway, New Jersey, United States

Outcomes

Primary Outcomes

Intensity of skin reactions is evaluated by 5 point grading scale

Time frame: Up to 72 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.